EMERGENT BIOSOLUTIONS INC (EBS)

US29089Q1058 - Common Stock

2.74  -0.06 (-2.14%)

After market: 2.85 +0.11 (+4.01%)

News Image
3 days ago - InvestorPlace

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?

Investors in Emergent Biosolutions and EBS stock certainly have a big catalyst to cheer today, as the company announced a new CEO.

News Image
3 days ago - Chartmill

Which stocks are experiencing notable movement on Wednesday?

These stocks are moving in today's session

News Image
3 days ago - Chartmill

Most active stocks in Wednesday's session

Which stocks are most active on Wednesday?

News Image
3 days ago - Chartmill

Which stocks are experiencing notable movement on Wednesday?

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

News Image
3 days ago - Chartmill

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Gap analysis on 2024-02-21: gap up and gap down stocks in today's session.

News Image
3 days ago - Seeking Alpha

Emergent BioSolutions appoints Joseph C. Papa as CEO (NYSE:EBS)

Joseph C. Papa has been appointed as the new president and CEO of Emergent BioSolutions, replacing Haywood Miller, effective February 21, 2024.

News Image
3 days ago - Emergent BioSolutions

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company’s debt GAITHERSBURG, Md.,...

News Image
24 days ago - InvestorPlace

Contrarian Calls: 7 Analyst ‘Sell’ Ratings That Should Be ‘Buys’

While it’s usually a good idea to trust Wall Street’s top experts, sometimes, it’s worthwhile to consider contrarian analyst picks.

News Image
2 months ago - Emergent BioSolutions

Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health...

News Image
2 months ago - InvestorPlace

Why Is Icosavax (ICVX) Stock Up 46% Today?

Icosavax stock is up on Tuesday as investors react to an acquisition deal with AstraZeneca that values ICVX between $15 and $20 per share.

News Image
2 months ago - InvestorPlace

EBS Stock Earnings: Emergent BioSolutions Misses EPS, Beats Revenue for Q3 2023

EBS stock results show that Emergent BioSolutions missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2023.

News Image
2 months ago - BusinessInsider

EBS Stock Earnings: Emergent BioSolutions Misses EPS, Beats Revenue for Q3 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Emergent BioSolutions (NYSE:EBS) just reported results for the third quarter of...

News Image
3 months ago - Seeking Alpha

Emergent Biosolutions wins $75 million contract option from BARDA (NYSE:EBS)

Emergent BioSolutions secures a $75 million contract option to acquire CYFENDUS, a newly licensed anthrax vaccine, from the Biomedical Advanced Research and...

News Image
3 months ago - Emergent BioSolutions

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and...

News Image
3 months ago - Seeking Alpha

JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower (NASDAQ:INSM)

JP Morgan said it was bullish on Insmed (INSM), Denali (DNLI), Immunocore (IMCR), Crinetics (CRNX), Mirum (MIRM) and BioCryst (BCRX), rating all as overweight. Read more here.

News Image
3 months ago - Emergent BioSolutions

Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing

GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today confirmed that on November 16, 2023, the New York Stock...

News Image
4 months ago - The Motley Fool

Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript

EBS earnings call for the period ending September 30, 2023.

News Image
4 months ago - Emergent BioSolutions

Emergent BioSolutions Reports Third Quarter 2023 Financial Results

Third Quarter 2023 Total Revenues of $271M, above the prior guidance rangeThird Quarter 2023 Pre-Tax Loss of  $(266)M and Adjusted EBITDA(2) of $20MUpdates...

News Image
4 months ago - Emergent BioSolutions

UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023

GAITHERSBURG, Md., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) has rescheduled its conference call to Wednesday, November 8,...

News Image
4 months ago - Emergent BioSolutions

Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023

GAITHERSBURG, Md., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 2, 2023, at...

News Image
4 months ago - Emergent BioSolutions

Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic

/PRNewswire/ -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced it is teaming up with football icon, Emmitt Smith, to break down the stigma around...

News Image
5 months ago - Emergent BioSolutions

Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors

GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Neal Fowler and Don...

News Image
6 months ago - Emergent BioSolutions

Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency

Emergent has officially shipped its over the counter, original prescription strength NARCAN® Naloxone HCl Nasal Spray 4 mg to leading mass, drug/pharmacy...